Regenerative medicine for liver diseases : Analysis of the development and differentiation of hepatic oval cells

肝病再生医学:肝卵圆细胞的发育和分化分析

基本信息

  • 批准号:
    15590356
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2004
  • 项目状态:
    已结题

项目摘要

We first examined the expression of Oncostatin M(OSM) and OSM-specific receptor(OSM-R) in the liver undergoing regeneration in the 2-acetylaminofluorene/partial hepatectomy(AAF/PH) model. OSM was expressed in both oval cells and Kupffer cells, but OSM-R was exclusively expressed in oval cells. When rat oval cells (OC15-5) were incubated in the conditioned medium of 293T cells expressing rat OSM cDNA, this resulted in suppression of growth, changes in morphology to possess microvilli and large cytoplasm with developed organells, and expression of hepatocyte markers, such as tyrosine amino transferase and tryptophan oxygenase, in OC15-5 cells. These results indicate that OSM is a key mediator for induction of the differentiation of OC15-5 cells into hepatocytes, and suggest that the OSM/OSM-R system plays a pivotal role in the differentiation of oval cells into hepatocytes, thereby promoting liver regeneration.Next, we examined the expression of Dlk in the AAF/PH model. Immunofluoresence staining analysis revealed that Dlk+ cells expressed oval cell markers, cytokeratin 19(CK19) and α-fetoprotein, indicating that Dlk is expressed in oval cells. However, Dl1k+ cells accounted for only about 20% of total CK19+ oval cells. Dlk+ cells were localized more distantly from the portal vein than Dlk- cells, and were adjacent to mature hepatocytes. Furthermore, at day 12 after PH, only 3% of Dlk+ oval cells expressed Ki67, whereas about 13% of total oval cells expressed Ki67, indicating that Dlk+ oval cells are less proliferative than Dlk- oval cells. Taken together, these results demonstrate that Dlk is expressed in a subpopulation of oval cells and that Dlk+ cells represent intermediate cells between Dlk- oval cells and mature hepatocytes.
我们首先检查了在2-乙酰氨基芴/部分肝切除术(AAF/PH)模型中经历再生的肝中的制瘤素M(OSM)和OSM特异性受体(OSM-R)的表达。OSM在卵圆细胞和枯否细胞中均有表达,但OSM-R仅在卵圆细胞中表达。当大鼠卵圆细胞(OC 15 -5)在表达大鼠OSM cDNA的293 T细胞的条件培养基中孵育时,这导致生长抑制,形态改变为具有微绒毛和具有发达细胞器的大细胞质,并且在OC 15 -5细胞中表达肝细胞标志物,如酪氨酸氨基转移酶和色氨酸加氧酶。这些结果表明OSM是诱导OC 15 -5细胞向肝细胞分化的关键介质,并表明OSM/OSM-R系统在卵圆细胞向肝细胞分化中起关键作用,从而促进肝再生。接下来,我们检测了Dlk在AAF/PH模型中的表达。免疫荧光染色显示Dlk+细胞表达卵圆细胞标志物细胞角蛋白19(CK 19)和甲胎蛋白,表明Dlk在卵圆细胞中表达。但Dl 1 k+细胞仅占CK 19+卵圆细胞总数的20%左右。Dlk+细胞比Dlk-细胞更远离门静脉定位,并且与成熟肝细胞相邻。此外,在PH后第12天,仅3%的Dlk+卵圆细胞表达Ki 67,而约13%的总卵圆细胞表达Ki 67,表明Dlk+卵圆细胞比Dlk-卵圆细胞增殖性低。综上所述,这些结果证明Dlk在卵圆细胞亚群中表达,并且Dlk+细胞代表Dlk-卵圆细胞和成熟肝细胞之间的中间细胞。

项目成果

期刊论文数量(37)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tanimizu N et al.: "Isolation of hepatoblasts based on the expression of Dlk/Pref-1"J Cell Sci. 116. 1775-1786 (2003)
Tanimizu N 等人:“基于 Dlk/Pref-1 表达的肝母细胞的分离”J Cell Sci。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
The origin of biliary ductular cells that appear in the spleen after transplantation of hepatocytes
  • DOI:
    10.3727/000000004772664860
  • 发表时间:
    2004-01-01
  • 期刊:
  • 影响因子:
    3.3
  • 作者:
    Fukuda, K;Sugihara, A;Terada, N
  • 通讯作者:
    Terada, N
Oncostatin M inhibits proliferation of rat oval cells, OC15-5, inducing differentiation into hepatocytes.
  • DOI:
    10.1016/s0002-9440(10)62292-4
  • 发表时间:
    2005-03
  • 期刊:
  • 影响因子:
    0
  • 作者:
    A. Okaya;J. Kitanaka;N. Kitanaka;M. Satake;Yuna Kim;K. Terada;T. Sugiyama;M. Takemura;J. Fujimoto;N. Terada;A. Miyajima;T. Tsujimura
  • 通讯作者:
    A. Okaya;J. Kitanaka;N. Kitanaka;M. Satake;Yuna Kim;K. Terada;T. Sugiyama;M. Takemura;J. Fujimoto;N. Terada;A. Miyajima;T. Tsujimura
Satake M et al.: "Role of c-kit receptor tyrosine kinase-mediated signal transduction in proliferation of bile epithelial cells in young rats after ligation of bile duct : A study using Ws/Ws c-kit mutant rats"J Hepatol. 39. 86-92 (2003)
Satake M 等人:“c-kit 受体酪氨酸激酶介导的信号转导对年轻大鼠胆管结扎后胆汁上皮细胞增殖的作用:使用 Ws/Ws c-kit 突变大鼠的研究”J Hepatol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Isolation of hepatoblasts based on the expression of Dlk/Pref-1
  • DOI:
    10.1242/jcs.00388
  • 发表时间:
    2003-05-01
  • 期刊:
  • 影响因子:
    4
  • 作者:
    Tanimizu, N;Nishikawa, M;Miyajima, A
  • 通讯作者:
    Miyajima, A
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TSUJIMURA Tohru其他文献

TSUJIMURA Tohru的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TSUJIMURA Tohru', 18)}}的其他基金

Analysis of mechanisms by which malignant pleural mesothelioma grows and invades: application to pathological diagnosis and development of a new therapy
恶性胸膜间皮瘤生长和侵袭机制分析:在病理诊断中的应用及新疗法的开发
  • 批准号:
    23590438
  • 财政年份:
    2011
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of early diagnosis of malignant mesothelioma : Comprehensive analysis of secretory and membrane proteins
恶性间皮瘤早期诊断的进展:分泌蛋白和膜蛋白的综合分析
  • 批准号:
    20590377
  • 财政年份:
    2008
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study on the differentiation of oval cells for the development of liver-targeted regenerative medicine
卵圆细胞分化研究,发展肝脏靶向再生医学
  • 批准号:
    17590363
  • 财政年份:
    2005
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of liver regeneration : A study using c-kit mutants
肝再生分析:使用 c-kit 突变体的研究
  • 批准号:
    13670232
  • 财政年份:
    2001
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of the signal transduction by c-kit receptor tyrosine kinase in the breast
c-kit受体酪氨酸激酶在乳腺信号转导中的作用
  • 批准号:
    11670230
  • 财政年份:
    1999
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanism of carcinogenesis by the mutations of c-kit gene
c-kit基因突变致癌机制
  • 批准号:
    09670225
  • 财政年份:
    1997
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Neoplastic transformation of mast cells through activating mutations of c-kit receptor
通过激活 c-kit 受体突变实现肥大细胞的肿瘤转化
  • 批准号:
    07670245
  • 财政年份:
    1995
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Senolytic trial for Aged Liver Regeneration Failure
老年肝脏再生失败的 Senolytic 试验
  • 批准号:
    23K19457
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
The role of liver progenitor cells in liver regeneration
肝祖细胞在肝再生中的作用
  • 批准号:
    10607301
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Promoting in vitro propagation of primary human hepatocytes as organoids using cues from natural liver regeneration
利用自然肝再生的线索促进原代人肝细胞作为类器官的体外增殖
  • 批准号:
    471981
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Fellowship Programs
A new role of pancreatic growth-related factors (REG3) in two-staged rapid liver regeneration
胰腺生长相关因子(REG3)在两阶段快速肝再生中的新作用
  • 批准号:
    22K08817
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Restoration and preservation of hepatic cardiolipin levels promotes liver regeneration in AH
肝心磷脂水平的恢复和保存促进 AH 中的肝再生
  • 批准号:
    10708057
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
Investigation of the role of VEGFA in harnessing cholangiocyte-driven liver regeneration
VEGFA 在利用胆管细胞驱动的肝再生中的作用的研究
  • 批准号:
    10631156
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
The cell identification research of bone marrow drived liver repaired cell in the new liver regeneration therapy
新型肝再生疗法中骨髓驱动的肝修复细胞的细胞鉴定研究
  • 批准号:
    22K08057
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
de novo approach to liver regeneration and liver disease focusing on PUFA containing phospholipids
以含有磷脂的 PUFA 为重点的肝再生和肝病从头方法
  • 批准号:
    22K08788
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Do Revival Stem Cells Contribute to Liver Regeneration?
复兴干细胞有助于肝脏再生吗?
  • 批准号:
    RGPIN-2020-07168
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Discovery Grants Program - Individual
Investigation of the role of VEGFA in harnessing cholangiocyte-driven liver regeneration
VEGFA 在利用胆管细胞驱动的肝再生中的作用的研究
  • 批准号:
    10501501
  • 财政年份:
    2022
  • 资助金额:
    $ 2.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了